JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, R. E.
Right arrow Articles by Weldon, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, R. E.
Right arrow Articles by Weldon, C. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 80, 696-701, Copyright © 1980 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Thymectomy for myasthenia gravis in the young adult. Long-term results

RE Clark, JP Marbarger, PN West, JA Spratt, JM Florence, CL Roper, TB Ferguson and CS Weldon

An 8 year experience with a prospective treatment program for patients with myasthenia gravis is reviewed with particular focus on the results in patients less than 35 years of age. Twenty myasthenic young adults with an average age of 24 years and a duration of symptoms of 22 months, excluding two with the juvenile form, had thymectomy followed by short-term anticholinesterase and long-term prednisone therapy. All of the 18 patients with a short duration of symptoms are in markedly improved condition and 61% of them are in remission after a mean postoperative period of 32 months. The longest follow-up period is 7.3 years. Two patients have mild improvement. There was no correlation between thymic disease and clinical result. Complete en bloc extirpation of all thymic and adjacent tissue through a median sternotomy is advocated. The patients were treated postoperatively with prednisone, 100 mg/day, a regimen which gradually is changed to every other day medication and finally a gradual reduction of dosage. There have been no operative or late deaths and no serious complications of therapy. The effects have been long lasting, with not a single instance of significant recurrence of symptoms of myasthenia gravis 6 months after thymectomy.


This article has been cited by other articles:


Home page
J Child NeurolHome page
H. K. Kolski, P. C.W. Kim, and J. Vajsar
Video-Assisted Thoracoscopic Thymectomy in Juvenile Myasthenia Gravis
J Child Neurol, August 1, 2001; 16(8): 569 - 573.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. K. Afifi and W. E. Bell
Tests for Juvenile Myasthenia Gravis: Comparative Diagnostic Yield and Prediction of Outcome
J Child Neurol, October 1, 1993; 8(4): 403 - 411.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1980 by The American Association for Thoracic Surgery.